Each capsule contains: Estrovade (Androst-3,5-dien-7, 17-dione) 80 mg • 19 nor DHEA (3b-enathoxy-19-nor-androst-4-ene-17-one) 20 mg • 1-DHEA (1-dehydroepiandrosterone; 3b-hydroxy-5a-androst-1-en-17-one) 60 mg. Other Ingredients: Maltodextrin, Gelatin, Silica, Magnesium Stearate, FD&C Red #40.
Brand name products often contain multiple ingredients. To read detailed information about each ingredient, click on the link for the individual ingredient shown above.
This is the currently available formulation of this product. A previously available formulation of this product was discontinued.
There is concern about this product because it contains a drug or drug-like substance that may not be safe when used without appropriate medical supervision.
This product has been discontinued by the manufacturer.
Below is general information about the effectiveness of the known ingredients contained in the product SOS 500. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
There is insufficient evidence about the effectiveness of 19-nor-DHEA.
INSUFFICIENT RELIABLE EVIDENCE to RATE
INSUFFICIENT RELIABLE EVIDENCE to RATE
Below is general information about the safety of the known ingredients contained in the product SOS 500. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
POSSIBLY UNSAFE ...when used orally or parenterally. The U.S. Food and Drug Administration and other regulatory agencies warn that dietary supplements containing aromatase inhibitors are dangerous. Adverse effects associated with aromatase inhibitors include aggressive behavior, adrenal insufficiency, decreased rate of bone maturation and growth, decreased sperm production, infertility, kidney failure, and liver dysfunction (91094,102468).
PREGNANCY AND LACTATION: POSSIBLY UNSAFE
when used orally or parenterally.
The U.S. Food and Drug Administration and other regulatory agencies warn that dietary supplements containing aromatase inhibitors are dangerous (91094). Avoid using.
Below is general information about the interactions of the known ingredients contained in the product SOS 500. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
19-nor-DHEA is purportedly converted to nandrolone and other androgens upon ingestion. Theoretically, taking 19-nor-DHEA with testosterone or other androgrens may increase the risk for additive adverse effects such as mood disturbances and cardiovascular, kidney, or liver problems.
|
1-Androsterone is converted to 1-testosterone and other androgens upon ingestion (90399,91095). Theoretically, taking 1-androsterone with testosterone might increase the risk for additive adverse effects such as mood disturbances and cardiovascular, kidney, or liver problems.
|
Below is general information about the adverse effects of the known ingredients contained in the product SOS 500. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
General ...There is insufficient information available about adverse effects associated with 19-nor-DHEA. However, because It is purported that 19-nor-DHEA is metabolized to anabolic compounds. Therefore, there is concern that it might cause serious anabolic steroid-like side effects including stroke, kidney failure, and liver injury.
General ...Clinical evidence evaluating the safety of 1-androsterone is lacking. However, in one preliminary clinical study, low-density lipoprotein (LDL) cholesterol levels were increased and high-density lipoprotein (HDL) cholesterol levels were decreased. Some patients also developed indicators of liver and kidney damage. In these patients, the liver enzyme aspartate transaminase (AST) and serum creatinine were significantly increased (91095).
Cardiovascular ...Significant increases in LDL cholesterol of around 29 mg/dL and significant decreases in HDL cholesterol of around 19 mg/dL have been reported in patients taking 1-androsterone for 4-weeks (91095).
Hepatic ...Significant increases in AST of around 15. 4 IU/L have been reported in patients taking 1-androsterone daily for 4 weeks. Despite the elevation, average AST levels did not go much beyond 40 IU/L, the upper limit of normal for AST (91095).
Renal ...Significant increases in serum creatinine of around 0. 2 mg/dL and significant decreases in GFR of around 16.4 mL/min/1.72m2 have been reported in patients taking 1-androsterone for 4 weeks. Serum creatinine remained within normal range despite the elevation, GFR dropped below 89 mL/min/1.72m2, which is suggestive of renal impairment (91095).